Angiotensin Antagonism in Coronary Artery Disease: Results after Coronary Revascularisation

Author： Ribichini Flavio   Ferrero Valeria   Rognoni Andrea   Vacca Giovanni   Vassanelli Corrado  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.8, 2005-01, pp. : 1073-1096

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological revascularisation in coronary and peripheral vascular disease

By Tarzami Sima T   Singh Jai Pal  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1319-1326

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Perindopril versus Angiotensin II Receptor Blockade in Hypertension and Coronary Artery Disease: Implications of Clinical Trials

By Brady Adrian J.B.  

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 149-161

Adis International

Access to resources Recommend Favorite